Detalhe da pesquisa
1.
Duplicate prescriptions in the emergency department: a retrospective cohort study.
Eur J Clin Pharmacol
; 79(2): 207-217, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36478283
2.
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels.
J Hepatol
; 76(5): 1042-1050, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35092743
3.
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE).
Clin Gastroenterol Hepatol
; 20(4): e784-e793, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33309804
4.
Low anti-HBc levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation in HBe antigen-negative patients.
Liver Int
; 42(12): 2674-2682, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152268
5.
Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern Germany.
BMC Gastroenterol
; 21(1): 296, 2021 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34284732
6.
Impact of the COVID-19 pandemic on patients with liver cirrhosis-the experience of a tertiary center in Germany.
Z Gastroenterol
; 59(9): 954-960, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34507374
7.
Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss.
J Infect Dis
; 217(10): 1656-1666, 2018 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29471497
8.
Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen-Negative Patients.
J Infect Dis
; 218(9): 1480-1484, 2018 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29893893
9.
Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B.
J Hepatol
; 69(3): 584-593, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29758333
10.
New viral biomarkers for Hepatitis B: Are we able to change practice?
J Viral Hepat
; 25(11): 1226-1235, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30187603
11.
Real-world effect of ribavirin on quality of life in HCV-infected patients receiving interferon-free treatment.
Liver Int
; 38(5): 834-841, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28960793
12.
Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications.
Br J Clin Pharmacol
; 84(5): 961-971, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29345798
13.
Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B.
J Infect Dis
; 214(10): 1492-1497, 2016 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27609808
14.
Drug-Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort.
Clin Infect Dis
; 62(5): 561-7, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26611779
15.
Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens.
J Hepatol
; 65(3): 473-82, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27085252
16.
S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion (AWMF-Register-Nr. 021-11).
Z Gastroenterol
; 59(7): 691-776, 2021 07.
Artigo
em Alemão
| MEDLINE | ID: mdl-34255317
17.
Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting.
Liver Int
; 35(7): 1845-52, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25556625
18.
Reply to Liaw.
J Infect Dis
; 218(11): 1853-1854, 2018 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29982785
19.
Concordance of emergency department physicians' decisions on HIV post-exposure prophylaxis with national guidelines: results from a retrospective cohort study.
Int Health
; 16(2): 219-226, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37624102
20.
Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos(t)ide Analogues in HBeAg-Negative CHB.
Hepatol Commun
; 5(1): 97-111, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33437904